Taiwan FDA registration f635a4cb3b1069d2dd74b7369e6ab347
Separation tube of Sixis platelet concentrate
TW: 艾粹絲血小板濃縮液分離管
Taiwan·Risk Class 2·碩方有限公司;; Asahi Biotechnology Co., Ltd·Registered Apr 09, 2021 – Apr 09, 2026ExpiredRegistration details
- Analysis ID
- f635a4cb3b1069d2dd74b7369e6ab347
Company information
- Manufacturer
- 碩方有限公司;; Asahi Biotechnology Co., Ltd
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- AGREE HEALTH CARE TECHNOLOGY, LTD.
Product details
- Intended Use
- This product prepares platelet-rich plasma (PRP) by centrifugation by drawing a small amount of peripheral blood from the patient.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.9245 Automated hemocytoseparator
- Import Information
- QMS/QSD;; 委託製造;; 國產
Dates and status
- Registration Date
- Apr 09, 2021
- Expiry Date
- Apr 09, 2026
About this record
Access comprehensive regulatory information for Separation tube of Sixis platelet concentrate in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f635a4cb3b1069d2dd74b7369e6ab347 and manufactured by 碩方有限公司;; Asahi Biotechnology Co., Ltd. The authorized representative in Taiwan is AGREE HEALTH CARE TECHNOLOGY, LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices